{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T22:48:19Z","timestamp":1785451699096,"version":"3.56.0"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T00:00:00Z","timestamp":1598313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T00:00:00Z","timestamp":1598313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000883","name":"University of Bristol","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000883","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Diab Rep"],"published-print":{"date-parts":[[2020,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Purpose of Review<\/jats:title><jats:p>An increased frequency of autoimmunity in children with Down syndrome (DS) is well described but few studies have investigated the underlying mechanisms. Recent immune system investigation of individuals with DS may shed light on the increased risk of autoimmune conditions including type 1 diabetes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Recent Findings<\/jats:title><jats:p>Diagnosis of type 1 diabetes is accelerated in children with DS with 17% diagnosed at, or under, the age of 2\u00a0years compared with only 4% in the same age group in the general population. Counterintuitively, children with DS and diabetes have less human leukocyte antigen (HLA)-mediated susceptibility than age-matched children with autoimmune diabetes from the general population. Early onset of diabetes in DS is further highlighted by the recent description of neonatal cases of diabetes which is autoimmune but not HLA associated. There are two potential explanations for this accelerated onset: (1) an additional chromosome 21 increases the genetic and immunological risk of autoimmune diabetes or (2) there are two separate aetiologies in children with DS and diabetes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Summary<\/jats:title><jats:p>Autoimmunity in DS is an under-investigated area. In this review, we will draw on recent mechanistic studies in individuals with DS which shed some light on the increased risk of autoimmunity in children with DS and consider the current support for and against two aetiologies underlying diabetes in children with DS.<\/jats:p><\/jats:sec>","DOI":"10.1007\/s11892-020-01318-8","type":"journal-article","created":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T01:02:36Z","timestamp":1598317356000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Early Onset of Autoimmune Diabetes in Children with Down Syndrome\u2014Two Separate Aetiologies or an Immune System Pre-Programmed for Autoimmunity?"],"prefix":"10.1007","volume":"20","author":[{"given":"Georgina L.","family":"Mortimer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen M.","family":"Gillespie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,25]]},"reference":[{"issue":"11","key":"1318_CR1","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.2105\/AJPH.2009.180273","volume":"100","author":"SL Thomas","year":"2010","unstructured":"Thomas SL, Griffiths C, Smeeth L, Rooney C, Hall AJ. Burden of mortality associated with autoimmune diseases among females in the United Kingdom. Am J Public Health. 2010;100(11):2279\u201387.","journal-title":"Am J Public Health"},{"issue":"4","key":"1318_CR2","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/ajmg.a.37001","volume":"167","author":"G De Graaf","year":"2015","unstructured":"De Graaf G, Buckley F, Skotko BG. Estimates of the live births, natural losses, and elective terminations with down syndrome in the United States. Am J Med Genet A. 2015;167(4):756\u201367.","journal-title":"Am J Med Genet A"},{"issue":"6","key":"1318_CR3","first-page":"664","volume":"99","author":"J Steele","year":"1992","unstructured":"Steele J, Stratford B. The United Kingdom population with down syndrome: present and future projections. Am J Ment Retard. 1992;99(6):664\u201382.","journal-title":"Am J Ment Retard"},{"issue":"1","key":"1318_CR4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s11689-019-9306-9","volume":"12","author":"C Startin","year":"2020","unstructured":"Startin C, D\u2019Souza H, Ball G, Hamburg S, Hithersay R, Hughes K, et al. Health comorbidities and cognitive abilities across the lifespan in down syndrome. J Neurodev Disord. 2020;12(1):4.","journal-title":"J Neurodev Disord"},{"key":"1318_CR5","doi-asserted-by":"crossref","unstructured":"Karlsson B, Gustafsson J, Hedov G, Ivarsson SA, Anneren G. Thyroid dysfunction in Down's syndrome: relation to age and thyroid autoimmunity. 1998;79(3):242\u20135.","DOI":"10.1136\/adc.79.3.242"},{"issue":"1","key":"1318_CR6","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/1096-8628(20010101)98:1<70::AID-AJMG1002>3.0.CO;2-G","volume":"98","author":"L Book","year":"2001","unstructured":"Book L, Hart A, Black J, Feolo M, Zone J, Neuhausen S. Prevalence and clinical characteristics of celiac disease in downs syndrome in a US study. Am J Med Genet. 2001;98(1):70\u20134.","journal-title":"Am J Med Genet"},{"key":"1318_CR7","doi-asserted-by":"crossref","unstructured":"Sanchez--Albisua I, Storm W, Wascher I, Stern M. How frequent is coeliac disease in Down syndrome? 2002;161(12):683\u20134.","DOI":"10.1007\/s00431-002-1078-6"},{"issue":"3","key":"1318_CR8","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1080\/00039896.1968.10665244","volume":"17","author":"A Milunsky","year":"1968","unstructured":"Milunsky A, Neurath P. Diabetes mellitus in Down's syndrome. Arch Environ Health. 1968;17(3):372\u20136.","journal-title":"Arch Environ Health"},{"issue":"04","key":"1318_CR9","first-page":"455","volume":"3","author":"DE Jeremiah","year":"1973","unstructured":"Jeremiah DE, Leyshon GE, Francis TRHWS, Elliott RW. Down's Syndrome and Diabetes. 1973;3(04):455.","journal-title":"Down's Syndrome and Diabetes"},{"issue":"2","key":"1318_CR10","first-page":"186","volume":"77","author":"JC Van Goor","year":"1997","unstructured":"Van Goor JC, Massa GG, Hirasing R. Increased incidence and prevalence of diabetes mellitus in Down's syndrome. 1997;77(2):186.","journal-title":"Increased incidence and prevalence of diabetes mellitus in Down's syndrome"},{"issue":"2","key":"1318_CR11","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/(SICI)1096-9136(199802)15:2<160::AID-DIA537>3.0.CO;2-J","volume":"15","author":"A Anwar","year":"1998","unstructured":"Anwar A, Walker J, Frier B. Type 1 diabetes mellitus and Down's syndrome: prevalence, management and diabetic complications. Diabet Med. 1998;15(2):160\u20133.","journal-title":"Diabet Med"},{"issue":"6","key":"1318_CR12","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s00125-006-0231-6","volume":"49","author":"R Bergholdt","year":"2006","unstructured":"Bergholdt R, Eising S, Nerup J, Pociot F. Increased prevalence of Down's syndrome in individuals with type 1 diabetes in Denmark: a nationwide population-based study. Diabetologia. 2006;49(6):1179\u201382.","journal-title":"Diabetologia."},{"key":"1318_CR13","doi-asserted-by":"crossref","unstructured":"Palmer J, Asplin C, Clemons P, Lyen K, Tatpati O, Raghu P et al. Insulin antibodies in insulin-dependent diabetics before insulin treatment. 1983;222(4630):1337\u20131339.","DOI":"10.1126\/science.6362005"},{"key":"1318_CR14","doi-asserted-by":"crossref","unstructured":"Baekkeskov S, Aanstoot H-J, Christgai S, Reetz A, Solimena M, Cascalho M et al. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. 1990;347(6289):151\u2013156.","DOI":"10.1038\/347151a0"},{"key":"1318_CR15","doi-asserted-by":"crossref","unstructured":"Hawkes CJ, Wasmeier C, Christie MR, Hutton JC. Identification of the 37-kDa antigen in IDDM as a tyrosine phosphatase-like protein (Phogrin) related to IA-2. 1996;45(9):1187\u20131192.","DOI":"10.2337\/diabetes.45.9.1187"},{"key":"1318_CR16","doi-asserted-by":"crossref","unstructured":"Bearzatto M, Naserke H, Piquer S, Koczwara K, Lampasona V, Williams A et al. Two distinctly HLA-associated contiguous linear epitopes uniquely expressed within the islet antigen 2 molecule are major autoantibody epitopes of the diabetes-specific tyrosine phosphatase-like protein autoantigens. 2002;168(8):4202\u20138.","DOI":"10.4049\/jimmunol.168.8.4202"},{"issue":"43","key":"1318_CR17","doi-asserted-by":"crossref","first-page":"17040","DOI":"10.1073\/pnas.0705894104","volume":"104","author":"JM Wenzlau","year":"2007","unstructured":"Wenzlau JM, Juhl K, Yu L, Moua O, Sarkar SA, Gottlieb P, et al. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci. 2007;104(43):17040\u20135.","journal-title":"Proc Natl Acad Sci"},{"issue":"6","key":"1318_CR18","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.2337\/db15-1058","volume":"65","author":"KA McLaughlin","year":"2016","unstructured":"McLaughlin KA, Richardson CC, Ravishankar A, Brigatti C, Liberati D, Lampasona V, et al. Identification of tetraspanin-7 as a target of autoantibodies in type 1 diabetes. Diabetes. 2016;65(6):1690\u20138.","journal-title":"Diabetes."},{"issue":"11","key":"1318_CR19","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.2337\/diab.46.11.1701","volume":"46","author":"PJ Bingley","year":"1997","unstructured":"Bingley PJ, Bonifacio E, Williams AJK, Genovese S, Bottazzo GF, Gale EAM. Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers. Diabetes. 1997;46(11):1701\u201310.","journal-title":"Diabetes."},{"issue":"3","key":"1318_CR20","doi-asserted-by":"crossref","first-page":"460","DOI":"10.2337\/diabetes.48.3.460","volume":"48","author":"AG Ziegler","year":"1999","unstructured":"Ziegler AG, Hummel M, Schenker M, Bonifacio E. Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB study. Diabetes. 1999;48(3):460\u20138.","journal-title":"Diabetes."},{"key":"1318_CR21","doi-asserted-by":"crossref","unstructured":"Rewers M, Hy\u00f6ty H, Lernmark \u00c5, Hagopian W, She J-X, Schatz D, et al. The Environmental Determinants of Diabetes in the Young (TEDDY) Study: 2018 Update. Current Diabetes Reports. 2018:18(12).","DOI":"10.1007\/s11892-018-1113-2"},{"key":"1318_CR22","doi-asserted-by":"crossref","unstructured":"Gillespie K, Dix R, Williams A, Newton R, Robinson Z, Bingley P, et al. Islet autoimmunity in children with down's syndrome. Diabetes. 2006;55(11):3185\u20138. The first study to demonstrate an increased frequency of islet autoimmunity in children with DS.","DOI":"10.2337\/db06-0856"},{"issue":"759","key":"1318_CR23","first-page":"554","volume":"293","author":"P Burch","year":"1969","unstructured":"Burch P, Milunsky A. Early-onset diabetes mellitus in the general and down's syndrome populations. Genetics, \u00c6tiology, and Pathogenesis Lancet. 1969;293(759):554\u20138.","journal-title":"Genetics, \u00c6tiology, and Pathogenesis Lancet"},{"key":"1318_CR24","doi-asserted-by":"crossref","unstructured":"Aitken R, Mehers K, Williams A, Brown J, Bingley P, Holl R, et al. Early-onset, coexisting autoimmunity and decreased HLA-mediated susceptibility are the characteristics of diabetes in down syndrome. Diabetes Care. 2013;36(5):1181\u20135. This paper shows that individuals with Down syndrome and diabetes also have a very high frequency of coeliac and thyroid autoimmunity, early onset of type 1 diabetes and decreased HLA mediated risk.","DOI":"10.2337\/dc12-1712"},{"key":"1318_CR25","doi-asserted-by":"crossref","unstructured":"Rohrer TR, Hennes P, Thon A, Dost A, Grabert M, Rami B, et al. Down\u2019s syndrome in diabetic patients aged <20 years: an analysis of metabolic status, glycaemic control and autoimmunity in comparison with type 1 diabetes. Diabetologia. 2010;53(6):1070\u20135. Detailed characterisation of diabetes in individuals with Down syndrome with diabetes among a very large population of German and Austrian children with diabetes. Demonstrates early onset of diabetes in some and good glycaemic control overall.","DOI":"10.1007\/s00125-010-1686-z"},{"key":"1318_CR26","doi-asserted-by":"crossref","unstructured":"Johnson MB, De Franco E, Greeley SAW, Letourneau LR, Gillespie KM, Wakeling MN, et al. Trisomy 21 is a cause of permanent neonatal diabetes that is autoimmune but not hla associated. Diabetes. 2019;68(7):1528\u201335. The first report of neonatal diabetes in children with Down syndrome.","DOI":"10.2337\/db19-0045"},{"issue":"3","key":"1318_CR27","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2337\/dc15-1111","volume":"39","author":"R Oram","year":"2016","unstructured":"Oram R, Patel K, Hill A, Shields B, McDonald T, Jones A, et al. A type 1 diabetes genetic risk score can aid discrimination between type 1 and type 2 diabetes in young adults. Diabetes Care. 2016;39(3):337\u201344.","journal-title":"Diabetes Care"},{"issue":"6","key":"1318_CR28","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1172\/JCI116110","volume":"90","author":"S Caillat-Zucman","year":"1992","unstructured":"Caillat-Zucman S, Garchon HJ, Timsit J, Assan R, Boitard C, Djilali-Saiah I, et al. Age-dependent HLA genetic heterogeneity of type 1 insulin-dependent diabetes mellitus. J Clin Investig. 1992;90(6):2242\u201350.","journal-title":"J Clin Investig"},{"issue":"5","key":"1318_CR29","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/BF00452061","volume":"29","author":"AK Foulis","year":"1986","unstructured":"Foulis AK, Liddle CN, Farquharson MA, Richmond JA, Weir RS. The histopathology of the pancreas in type I (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom. Diabetologia. 1986;29(5):267\u201374.","journal-title":"Diabetologia."},{"issue":"1","key":"1318_CR30","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0896-8411(89)90105-4","volume":"2","author":"SL Rabinowe","year":"1989","unstructured":"Rabinowe SL, Rubin IL, George KL, Adri MN, Eisenbarth GS. Trisomy 21 (Down's syndrome): autoimmunity, aging and monoclonal antibody-defined T-cell abnormalities. J Autoimmun. 1989;2(1):25\u201330.","journal-title":"J Autoimmun"},{"issue":"7","key":"1318_CR31","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.2337\/diacare.20.7.1202b","volume":"20","author":"ME Griffin","year":"1997","unstructured":"Griffin ME, Fulcher T, Nikookam K, Crowley J, Firth RG, O'Meara NM. Down's syndrome, IDDM, and hypothyroidism. Diabetes Care. 1997;20(7):1202\u20133.","journal-title":"Diabetes Care"},{"issue":"2","key":"1318_CR32","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/adc.81.2.147","volume":"81","author":"JP Shield","year":"1999","unstructured":"Shield JP, Wadsworth EJ, Hassold TJ, Judis LA, Jacobs PA. Is disomic homozygosity at the APECED locus the cause of increased autoimmunity in Down's syndrome? Arch Dis Child. 1999;81(2):147\u201350.","journal-title":"Arch Dis Child"},{"issue":"4","key":"1318_CR33","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/00005176-200110000-00008","volume":"33","author":"AN Aktay","year":"2001","unstructured":"Aktay AN, Lee PC, Kumar V, Parton E, Wyatt DT, Werlin SL. The prevalence and clinical characteristics of celiac disease in juvenile diabetes in Wisconsin. J Pediatr Gastroenterol Nutr. 2001;33(4):462\u20135.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"44","key":"1318_CR34","first-page":"2489","volume":"143","author":"H Makovi","year":"2002","unstructured":"Makovi H, Soltesz G, Hermann R. Clinical heterogeneity of childhood diabetes in Baranya county. Orv Hetil. 2002;143(44):2489\u201392.","journal-title":"Orv Hetil"},{"issue":"2","key":"1318_CR35","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.dsx.2012.08.006","volume":"6","author":"SK Kota","year":"2012","unstructured":"Kota SK, Meher LK, Jammula S, Kota SK, Modi KD. Clinical profile of coexisting conditions in type 1 diabetes mellitus patients. Diabetes Metabo Syndr. 2012;6(2):70\u20136.","journal-title":"Diabetes Metabo Syndr"},{"issue":"10","key":"1318_CR36","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1055\/s-0032-1306330","volume":"120","author":"F Schmidt","year":"2012","unstructured":"Schmidt F, Kapellen TM, Wiegand S, Herbst A, Wolf J, Frohlich-Reiterer EE, et al. Diabetes mellitus in children and adolescents with genetic syndromes. Experimental and clinical endocrinology & diabetes : official journal. German Society of Endocrinology [and] German Diabetes Association. 2012;120(10):579\u201385.","journal-title":"German Society of Endocrinology [and] German Diabetes Association"},{"issue":"12","key":"1318_CR37","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1111\/j.1365-2788.2012.01633.x","volume":"57","author":"L Taggart","year":"2013","unstructured":"Taggart L, Coates V, Truesdale-Kennedy M. Management and quality indicators of diabetes mellitus in people with intellectual disabilities. J Intellect Disabil Res : JIDR. 2013;57(12):1152\u201363.","journal-title":"J Intellect Disabil Res : JIDR"},{"issue":"9","key":"1318_CR38","first-page":"1041","volume":"29","author":"T Aversa","year":"2016","unstructured":"Aversa T, Valenzise M, Corrias A, Salerno M, Iughetti L, Tessaris D, et al. In children with autoimmune thyroid diseases the association with down syndrome can modify the clustering of extra-thyroidal autoimmune disorders. J Pediatr Endocr Met : JPEM. 2016;29(9):1041\u20136.","journal-title":"J Pediatr Endocr Met : JPEM"},{"issue":"5","key":"1318_CR39","doi-asserted-by":"crossref","first-page":"387","DOI":"10.5001\/omj.2018.72","volume":"33","author":"Y Abdulrazzaq","year":"2018","unstructured":"Abdulrazzaq Y, El-Azzabi TI, Al Hamad SM, Attia S, Deeb A, Aburawi EH. Occurrence of hypothyroidism, diabetes mellitus, and celiac disease in emirati children with down's syndrome. Oman Med J. 2018;33(5):387\u201392.","journal-title":"Oman Med J"},{"issue":"1","key":"1318_CR40","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1210\/js.2016-1042","volume":"1","author":"A Butler","year":"2017","unstructured":"Butler A, Sacks W, Rizza R, Butler P. Down syndrome-associated diabetes is not due to a congenital deficiency in beta cells. Journal of the Endocrine Society. 2017;1(1):39\u201345.","journal-title":"Journal of the Endocrine Society"},{"key":"1318_CR41","doi-asserted-by":"crossref","unstructured":"Murphy M, Epstein LB. Down syndrome (trisomy 21) thymuses have a decreased proportion of cells expressing high levels of TCR\u03b1,\u03b2 and CD3. 1990;55(3):453\u2013467.","DOI":"10.1016\/0090-1229(90)90131-9"},{"key":"1318_CR42","doi-asserted-by":"crossref","unstructured":"Levin S, Schlesinger M, Handzel Z, Hahn T, Altman Y, Czernobilsky B, et al. Thymic deficiency in down\u2019s syndrome. Pediatrics. 1979, 63(80).","DOI":"10.1542\/peds.63.1.80"},{"key":"1318_CR43","first-page":"225","volume":"7","author":"L Larocca","year":"1990","unstructured":"Larocca L, Lauriola L, Ranelletti F, Piantelli M, Maggiano N, Ricci R, et al. Morphological and immunohistochemical study of down syndrome thymus. Am J Med Genet. 1990;7:225\u201330.","journal-title":"Am J Med Genet"},{"issue":"7","key":"1318_CR44","doi-asserted-by":"crossref","first-page":"4500","DOI":"10.4049\/jimmunol.1001700","volume":"186","author":"B Bloemers","year":"2011","unstructured":"Bloemers B, Bont L, de Weger R, Otto S, Borghans J, Tesselaar K. Decreased thymic output accounts for decreased naive T cell numbers in children with down syndrome. J Immunol. 2011;186(7):4500\u20137.","journal-title":"J Immunol"},{"key":"1318_CR45","doi-asserted-by":"crossref","unstructured":"Prada N, Nasi M, Troiano L, Roat E, Pinti M, Nemes E, et al. Direct analysis of thymic function in children with Down's syndrome. Immunity and Ageing. 2005:16(2).","DOI":"10.1186\/1742-4933-2-4"},{"issue":"6","key":"1318_CR46","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jpeds.2005.07.022","volume":"147","author":"Y de Hingh","year":"2005","unstructured":"de Hingh Y, van der Vossen P, Gemen E, Mulder A, Hop W, Brus F, et al. Intrinsic abnormalities of lymphocyte counts in children with down syndrome. J Pediatr. 2005;147(6):744\u20137.","journal-title":"J Pediatr"},{"issue":"2","key":"1318_CR47","first-page":"298","volume":"33","author":"GR Burgio","year":"1978","unstructured":"Burgio GR, Lanzavecchia A, Maccario R, Vitiello A, Plebani A, Ugazio AG. Immunodeficiency in Down's syndrome: T-lymphocyte subset imbalance in trisomic children. Clin Exp Immunol. 1978;33(2):298\u2013301.","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"1318_CR48","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1006\/clin.1996.0031","volume":"78","author":"E Cuadrado","year":"1996","unstructured":"Cuadrado E, Barrena MJ. Immune dysfunction in down's syndrome: primary immune deficiency or early senescence of the immune system? Clin Immunol Immunopathol. 1996;78(3):209\u201314.","journal-title":"Clin Immunol Immunopathol"},{"issue":"1","key":"1318_CR49","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1365-2249.1990.tb05128.x","volume":"79","author":"S Raziuddin","year":"1990","unstructured":"Raziuddin S, Elawad ME. Immunoregulatory CD4+ CD45R+ suppressor\/inducer T lymphocyte subsets and impaired cell-mediated immunity in patients with Down's syndrome. Clin Exp Immunol. 1990;79(1):67\u201371.","journal-title":"Clin Exp Immunol"},{"key":"1318_CR50","doi-asserted-by":"crossref","unstructured":"Scotese I, Gaetaniello L, Matarese G, Lecora M, Racioppi L, Pignata C. T Cell activation deficiency associated with an aberrant pattern of protein tyrosine phosphorylation after CD3 perturbation in down's syndrome. 1998;44(2):252\u2013258.","DOI":"10.1203\/00006450-199808000-00019"},{"key":"1318_CR51","first-page":"213","volume":"7","author":"A Cossarizza","year":"1990","unstructured":"Cossarizza A, Monti D, Montagnani G, Ortolani C, Masi M, Zannotti M, et al. Precocious aging of the immune system in down syndrome: alteration of B lymphocytes, T-lymphocyte subsets, and cells with natural killer markers. Am J Med Genet Suppl. 1990;7:213\u20138.","journal-title":"Am J Med Genet Suppl"},{"key":"1318_CR52","first-page":"204","volume":"7","author":"AG Ugazio","year":"1990","unstructured":"Ugazio AG, Maccario R, Notarangelo LD, Burgio GR. Immunology of down syndrome: a review. Am J Med Genet Suppl. 1990;7:204\u201312.","journal-title":"Am J Med Genet Suppl"},{"key":"1318_CR53","doi-asserted-by":"crossref","unstructured":"Sullivan KD, Evans D, Pandey A, Hraha TH, Smith KP, Markham N, et al. Trisomy 21 causes changes in the circulating proteome indicative of chronic autoinflammation. Sci Rep. 2017;7(1):14818. Proteomics approach showing that individuals with DS have high circulating levels of pro-inflammatory cytokines (IL6, MCP-1, IL22, TNFalpha).","DOI":"10.1038\/s41598-017-13858-3"},{"issue":"48","key":"1318_CR54","doi-asserted-by":"crossref","first-page":"24231","DOI":"10.1073\/pnas.1908129116","volume":"116","author":"P Araya","year":"2019","unstructured":"Araya P, Waugh KA, Sullivan KD, N\u00fa\u00f1ez NG, Roselli E, Smith KP, et al. Trisomy 21 dysregulates T cell lineages toward an autoimmunity-prone state associated with interferon hyperactivity. Proc Natl Acad Sci. 2019;116(48):24231\u201341. Important study of T cells in individuals with DS providing evidence for elevated levels of basal IFN signalling and interferon hyperreactivity that may contribute to increased autoimmunity in DS.","journal-title":"Proc Natl Acad Sci"},{"key":"1318_CR55","doi-asserted-by":"crossref","unstructured":"Waugh KA, Araya P, Pandey A, Jordan KR, Smith KP, Granrath RE, et al. Mass cytometry reveals global immune remodeling with multi-lineage hypersensitivity to type i interferon in down syndrome. Cell Rep. 2019;29(7):1893\u2013908.e4. Mass cytometry approaches were used to reveal a proinflammatory state with widespread hypersensitivity to INN alpha in individuals with Down syndrome.","DOI":"10.1016\/j.celrep.2019.10.038"},{"issue":"7","key":"1318_CR56","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.2337\/db13-1777","volume":"63","author":"RC Ferreira","year":"2014","unstructured":"Ferreira RC, Guo H, Coulson RMR, Smyth DJ, Pekalski ML, Burren OS, et al. A type I interferon transcriptional signature precedes autoimmunity in children genetically at risk for type 1 diabetes. Diabetes. 2014;63(7):2538\u201350.","journal-title":"Diabetes."},{"key":"1318_CR57","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jaut.2018.08.003","volume":"94","author":"A Lombardi","year":"2018","unstructured":"Lombardi A, Tsomos E, Hammerstad SS, Tomer Y. Interferon alpha: the key trigger of type 1 diabetes. J Autoimmun. 2018;94:7\u201315.","journal-title":"J Autoimmun"},{"issue":"12","key":"1318_CR58","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1002\/ajmg.a.37366","volume":"167","author":"JK Morris","year":"2015","unstructured":"Morris JK, Cole TJ, Springett AL, Dennis J. Down syndrome birth weight in England and Wales: implications for clinical practice. Am J Med Genet A. 2015;167(12):3070\u20135.","journal-title":"Am J Med Genet A"},{"issue":"3","key":"1318_CR59","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1007\/s00125-017-4493-y","volume":"61","author":"RR Goldacre","year":"2018","unstructured":"Goldacre RR. Associations between birthweight, gestational age at birth and subsequent type 1 diabetes in children under 12: a retrospective cohort study in England, 1998\u20132012. Diabetologia. 2018;61(3):616\u201325.","journal-title":"Diabetologia."},{"issue":"10","key":"1318_CR60","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1007\/s00125-017-4365-5","volume":"60","author":"M L\u00f6nnrot","year":"2017","unstructured":"L\u00f6nnrot M, Lynch KF, Elding Larsson H, Lernmark \u00c5, Rewers MJ, T\u00f6rn C, et al. Respiratory infections are temporally associated with initiation of type 1 diabetes autoimmunity: the TEDDY study. Diabetologia. 2017;60(10):1931\u201340.","journal-title":"Diabetologia."},{"issue":"12","key":"1318_CR61","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.2337\/dc12-0423","volume":"35","author":"JK Snell-Bergeon","year":"2012","unstructured":"Snell-Bergeon JK, Smith J, Dong F, Baron AE, Barriga K, Norris JM, et al. Early childhood infections and the risk of islet autoimmunity: the diabetes autoimmunity study in the young (DAISY). Diabetes Care. 2012;35(12):2553\u20138.","journal-title":"Diabetes Care"},{"issue":"5","key":"1318_CR62","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1093\/ije\/dyy092","volume":"47","author":"G Tapia","year":"2018","unstructured":"Tapia G, St\u00f8rdal K, M\u00e5rild K, Kahrs CR, Skrivarhaug T, Nj\u00f8lstad PR, et al. Antibiotics, acetaminophen and infections during prenatal and early life in relation to type 1 diabetes. Int J Epidemiol. 2018;47(5):1538\u201348.","journal-title":"Int J Epidemiol"},{"issue":"9","key":"1318_CR63","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1111\/apa.13937","volume":"106","author":"V Grut","year":"2017","unstructured":"Grut V, S\u00f6derstr\u00f6m L, Naumburg E. National cohort study showed that infants with Down's syndrome faced a high risk of hospitalisation for the respiratory syncytial virus. Acta Paediatr. 2017;106(9):1519\u201324.","journal-title":"Acta Paediatr"},{"issue":"9","key":"1318_CR64","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/jir.12196","volume":"59","author":"H Uppal","year":"2015","unstructured":"Uppal H, Chandran S, Potluri R. Risk factors for mortality in down syndrome. J Intellect Disabil Res. 2015;59(9):873\u201381.","journal-title":"J Intellect Disabil Res"},{"issue":"7728","key":"1318_CR65","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-018-0617-x","volume":"562","author":"CJ Stewart","year":"2018","unstructured":"Stewart CJ, Ajami NJ, O\u2019Brien JL, Hutchinson DS, Smith DP, Wong MC, et al. Temporal development of the gut microbiome in early childhood from the TEDDY study. Nature. 2018;562(7728):583\u20138.","journal-title":"Nature."},{"issue":"7728","key":"1318_CR66","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41586-018-0620-2","volume":"562","author":"T Vatanen","year":"2018","unstructured":"Vatanen T, Franzosa EA, Schwager R, Tripathi S, Arthur TD, Vehik K, et al. The human gut microbiome in early-onset type 1 diabetes from the TEDDY study. Nature. 2018;562(7728):589\u201394.","journal-title":"Nature."},{"issue":"5","key":"1318_CR67","first-page":"574","volume":"20","author":"JE Harbison","year":"2019","unstructured":"Harbison JE, Roth-Schulze AJ, Giles LC, Tran CD, Ngui KM, Penno MA, et al. Gut microbiome dysbiosis and increased intestinal permeability in children with islet autoimmunity and type 1 diabetes: a prospective cohort study. Pediatr Diabetes. 2019;20(5):574\u201383.","journal-title":"Pediatr Diabetes"},{"key":"1318_CR68","doi-asserted-by":"crossref","unstructured":"Biagi E, Candela M, Centanni M, Consolandi C, Rampelli S, Turroni S et al. Gut microbiome in down syndrome. 2014;9(11):e112023.","DOI":"10.1371\/journal.pone.0112023"},{"issue":"4","key":"1318_CR69","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/ejhg.2008.214","volume":"17","author":"R Lyle","year":"2009","unstructured":"Lyle R, B\u00e9na F, Gagos S, Gehrig C, Lopez G, Schinzel A, et al. Genotype-phenotype correlations in down syndrome identified by array CGH in 30 cases of partial trisomy and partial monosomy chromosome 21. Eur J Hum Genet : EJHG. 2009;17(4):454\u201366.","journal-title":"Eur J Hum Genet : EJHG"},{"key":"1318_CR70","first-page":"24","volume":"7","author":"C-M Li","year":"2006","unstructured":"Li C-M, Guo M, Salas M, Schupf N, Silverman W, Zigman WB, et al. Cell type-specific over-expression of chromosome 21 genes in fibroblasts and fetal hearts with trisomy 21. BMC Med Genet. 2006;7:24.","journal-title":"BMC Med Genet"},{"issue":"2","key":"1318_CR71","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1086\/519248","volume":"81","author":"P Prandini","year":"2007","unstructured":"Prandini P, Deutsch S, Lyle R, Gagnebin M, Delucinge Vivier C, Delorenzi M, et al. Natural gene-expression variation in down syndrome modulates the outcome of gene-dosage imbalance. Am J Hum Genet. 2007;81(2):252\u201363.","journal-title":"Am J Hum Genet"},{"issue":"3","key":"1318_CR72","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/cei.13115","volume":"192","author":"A Kozhakhmetova","year":"2018","unstructured":"Kozhakhmetova A, Wyatt RC, Caygill C, Williams C, Long AE, Chandler K, et al. A quarter of patients with type 1 diabetes have co-existing non-islet autoimmunity: the findings of a UK population-based family study. Clin Exp Immunol. 2018;192(3):251\u20138.","journal-title":"Clin Exp Immunol"},{"issue":"10","key":"1318_CR73","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.2337\/db08-0753","volume":"57","author":"P Concannon","year":"2008","unstructured":"Concannon P, Onengut-Gumuscu S, Todd JA, Smyth DJ, Pociot F, Bergholdt R, et al. A human type 1 diabetes susceptibility locus maps to chromosome 21q22.3. Diabetes. 2008;57(10):2858\u201361.","journal-title":"Diabetes."},{"key":"1318_CR74","doi-asserted-by":"crossref","unstructured":"Grant SFA, Qu HQ, Bradfield JP, Marchand L, Kim CE, Glessner JT et al. Follow-up analysis of genome-wide association data identifies novel loci for type 1 diabetes. 2009;58(1):290\u2013295.","DOI":"10.2337\/db08-1022"},{"issue":"2","key":"1318_CR75","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002004","volume":"7","author":"A Zhernakova","year":"2011","unstructured":"Zhernakova A, Stahl EA, Trynka G, Raychaudhuri S, Festen EA, Franke L, et al. Meta-analysis of genome-wide association studies in celiac disease and rheumatoid arthritis identifies fourteen non-HLA shared loci. PLoS Genet. 2011;7(2):e1002004.","journal-title":"PLoS Genet"},{"issue":"2","key":"1318_CR76","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s004390000453","volume":"108","author":"M Wattenhofer","year":"2001","unstructured":"Wattenhofer M, Shibuya K, Kudoh J, Lyle R, Michaud J, Rossier C, et al. Isolation and characterization of the UBASH3A gene on 21q22.3 encoding a potential nuclear protein with a novel combination of domains. Hum Genet. 2001;108(2):140\u20137.","journal-title":"Hum Genet"},{"issue":"7","key":"1318_CR77","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/s41431-018-0123-5","volume":"26","author":"Y Ge","year":"2018","unstructured":"Ge Y, Concannon P. Molecular-genetic characterization of common, noncoding UBASH3A variants associated with type 1 diabetes. Eur J Hum Genet. 2018;26(7):1060\u20134.","journal-title":"Eur J Hum Genet"},{"issue":"5","key":"1318_CR78","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.4049\/jimmunol.1400742","volume":"193","author":"G Skogberg","year":"2014","unstructured":"Skogberg G, Lundberg V, Lindgren S, Gudmundsdottir J, Sandstr\u00f6m K, K\u00e4mpe O, et al. Altered expression of autoimmune regulator in infant down syndrome thymus, a possible contributor to an autoimmune phenotype. J Immunol. 2014;193(5):2187\u201395.","journal-title":"J Immunol"},{"key":"1318_CR79","doi-asserted-by":"crossref","unstructured":"Lima FA, Moreira-Filho CA, Ramos PL, Brentani H, Lima LdA, Arrais M et al. Decreased AIRE expression and global thymic hypofunction in down syndrome. 2011;187(6):3422\u20133430.","DOI":"10.4049\/jimmunol.1003053"},{"key":"1318_CR80","doi-asserted-by":"crossref","unstructured":"Gim\u00e9nez-Barcons M, Caster\u00e0s A, Armengol MdP, Porta E, Correa PA, Mar\u00edn A et al. Autoimmune predisposition in down syndrome may result from a partial central tolerance failure due to insufficient intrathymic expression of AIRE and peripheral antigens. 2014;193(8):3872\u20133879.","DOI":"10.4049\/jimmunol.1400223"},{"issue":"5","key":"1318_CR81","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/icb.2012.9","volume":"90","author":"NA De Weerd","year":"2012","unstructured":"De Weerd NA, Nguyen T. The interferons and their receptors-distribution and regulation. Immunol Cell Biol. 2012;90(5):483\u201391.","journal-title":"Immunol Cell Biol"},{"key":"1318_CR82","unstructured":"Khor B, Gagnon JD, Goel G, Roche MI, Conway KL, Tran K, et al. The kinase DYRK1A reciprocally regulates the differentiation of Th17 and regulatory T cells. eLife. 2015;4. This key publication links DYRK1A to the function of the immune system."},{"issue":"8","key":"1318_CR83","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1136\/archdischild-2017-314312","volume":"103","author":"GM Williams","year":"2018","unstructured":"Williams GM, Neville P, Gillespie KM, Leary SD, Hamilton-Shield JP, Searle AJ. What factors influence recruitment to a birth cohort of infants with Down's syndrome? Arch Dis Child. 2018;103(8):763\u20136.","journal-title":"Arch Dis Child"}],"container-title":["Current Diabetes Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11892-020-01318-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11892-020-01318-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11892-020-01318-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T07:24:51Z","timestamp":1696577091000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11892-020-01318-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,25]]},"references-count":83,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["1318"],"URL":"https:\/\/doi.org\/10.1007\/s11892-020-01318-8","relation":{},"ISSN":["1534-4827","1539-0829"],"issn-type":[{"value":"1534-4827","type":"print"},{"value":"1539-0829","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,25]]},"assertion":[{"value":"25 August 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"47"}}